www.corcept.com
Open in
urlscan Pro
35.193.101.241
Public Scan
Submitted URL: http://corcept.com/
Effective URL: https://www.corcept.com/
Submission: On March 13 via manual from SG — Scanned from SG
Effective URL: https://www.corcept.com/
Submission: On March 13 via manual from SG — Scanned from SG
Form analysis
1 forms found in the DOMGET https://www.corcept.com
<form role="search" method="get" class="search-form" action="https://www.corcept.com">
<div><label for="s" class="search-form__label">Search</label><input placeholder="" type="text" value="" name="s" class="search-input" autocomplete="off"><button type="submit" class="search-button" value="Search">Search</button>
</div>
</form>
Text Content
Skip to content Main Menu * Contact Us * SearchSearch * AboutShow submenu * About Corcept * Executive Team * Board of Directors * Educational Grants * Contact Us * ProductShow submenu * Korlym® for Cushing Syndrome * Medical Information Request * Patients * Research & PipelineShow submenu * Cortisol Modulation * Cortisol Modulation Therapeutic Platform * Pipeline and Clinical Trials * Publications * Investigator-Initiated Studies * Compassionate Use * InvestorsShow submenu * Investors Overview * Press Releases * Events * Corporate Governance * Analyst Coverage * Stock Information * SEC Filings * CareersShow submenu * Working at Corcept * Benefits * Testimonials * Current Opportunities PIONEERING THE DISCOVERY AND DEVELOPMENT OF CORTISOL MODULATORS Developing cortisol modulators for a broad range of serious diseases, including endocrine, metabolic, oncologic, and psychiatric disorders Scroll Down COMMITMENT TOSCIENCE We lead the field in the research and development of selective glucocorticoid receptor (GR) antagonists. IMPACT OF EXCESS CORTISOL AND UNDERSTANDING GR ANTAGONISM Learn More RESEARCH & PIPELINE Learn More COMMITMENT TOPATIENTS We are committed to developing novel medications for patients suffering from diseases driven by cortisol dysregulation. Learn More COMMITMENT TOCULTURE We foster a diverse and collaborative environment focused on developing novel therapies that help treat people with serious unmet medical needs. Learn More * * Science * Patients * Culture * About * Executive Team * Board of Directors * Educational Grants * Contact Us * Product * Korlym for Cushing Syndrome * Medical Information Request * Patients * Research & Pipeline * Cortisol Modulation * Cortisol Modulation Therapeutic Platform * Pipeline and Clinical Trials * Publications * Investigator-Initiated Studies * Compassionate Use * Investors * Investors Overview * Press Releases * Events * Corporate Governance * Analyst Coverage * Stock Information * SEC Filings * Careers * Benefits * Testimonials * Current Opportunities © 2023 Corcept * Privacy Notice * Terms of Use * Site Map This website uses cookies to help us give you the best experience when you visit. By continuing to use this website, you consent to the use of these cookies. To find out more about how we use cookies and how you can manage them go to our Cookie Notice. Accept